Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARTESiA: Apixaban vs Aspirin in Sub-Clinical Atrial Fibrillation
NCT01938248Phase 4Completed
- Sponsor
- Population Health Research Institute
- Start
- May 2015
- Primary completion
- Oct 2023
- Modality
- Small Molecules
- Countries
- 13
01
Overview
A Phase 4 trial of apixaban in Atrial fibrillation (AFib), sponsored by Population Health Research Institute. Started May 2015; status: completed.
02
Drugs
apixaban
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT01938248.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01938248.